HCA Midwest Health - SCRI - PPDS — Kansas City, Missouri

HCA Midwest Health - SCRI - PPDS is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

HCA Midwest Health - SCRI - PPDS has participated in 3 clinical trials.

Therapeutic areas: Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.

Sponsors: Takeda, Spexis AG.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HCA Midwest Health - SCRI - PPDS?

HCA Midwest Health - SCRI - PPDS has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HCA Midwest Health - SCRI - PPDS conducted?

HCA Midwest Health - SCRI - PPDS has 3 clinical trials on record. Their work covers Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.

Is HCA Midwest Health - SCRI - PPDS accredited by Crixeo Health?

HCA Midwest Health - SCRI - PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HCA Midwest Health - SCRI - PPDS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.